Huaren Pharmaceutical Co., Ltd. (SHE:300110)
China · Delayed Price · Currency is CNY 2.820
-0.040 (-1.40%)
Sep 10, 2026, 3:04 PM CST
Huaren Pharmaceutical Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 212.74 | 138.97 | 163.81 | 232.04 | 221.71 | 417.15 |
Cash & Short-Term Investments | 212.74 | 138.97 | 163.81 | 232.04 | 221.71 | 417.15 |
Cash Growth | 0.79% | -15.16% | -29.40% | 4.66% | -46.85% | 82.42% |
Accounts Receivable | 561.21 | 555.21 | 628.45 | 806.11 | 739.22 | 887.34 |
Other Receivables | 21.1 | 21.21 | 34.71 | 1,364 | 1,430 | 1,419 |
Receivables | 582.31 | 576.42 | 663.15 | 2,170 | 2,169 | 2,306 |
Inventory | 239.99 | 241.51 | 318.24 | 334.63 | 266.85 | 275.47 |
Other Current Assets | 54.49 | 36.98 | 39.77 | 54.51 | 71.8 | 109.27 |
Total Current Assets | 1,090 | 993.88 | 1,185 | 2,791 | 2,730 | 3,108 |
Property, Plant & Equipment | 1,052 | 1,094 | 1,076 | 1,116 | 1,139 | 1,219 |
Long-Term Investments | 15.98 | 16.58 | 16.58 | 16.58 | 16.58 | 16.58 |
Goodwill | 207.89 | 207.89 | 732.61 | 820.04 | 826.29 | 826.64 |
Other Intangible Assets | 273.08 | 284.05 | 301.7 | 318.53 | 331.77 | 366.16 |
Long-Term Deferred Tax Assets | 71.12 | 70.99 | 57.19 | 42.03 | 56.87 | 46.4 |
Long-Term Deferred Charges | 8.34 | 9.72 | 18.13 | 29.1 | 27.15 | 22.6 |
Other Long-Term Assets | 31.99 | 25.29 | 40.88 | 32.13 | 35.72 | 36.58 |
Total Assets | 2,750 | 2,702 | 3,428 | 5,166 | 5,163 | 5,642 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Accounts Payable | 180.86 | 199.9 | 147.35 | 142.32 | 122.75 | 127.08 |
Accrued Expenses | 14.29 | 211.08 | 185.72 | 192.22 | 206.03 | 183.32 |
Short-Term Debt | 429.9 | 330.42 | 424.41 | 624.83 | 1,218 | 1,579 |
Current Portion of Long-Term Debt | 448.6 | 329.51 | 389.02 | 101.8 | 98.96 | 29.96 |
Current Portion of Leases | - | 0.42 | - | 0.59 | 1.08 | 0.86 |
Current Income Taxes Payable | 14.91 | 11.91 | 9.83 | 15.93 | 32.78 | 28.54 |
Current Unearned Revenue | 30.98 | 35.4 | 32.46 | 55.55 | 32 | 28.17 |
Other Current Liabilities | 241.51 | 355.89 | 357.84 | 383.01 | 317.41 | 613.99 |
Total Current Liabilities | 1,361 | 1,475 | 1,547 | 1,516 | 2,029 | 2,591 |
Long-Term Debt | 400.74 | 270.22 | 464.08 | 836.42 | 352.74 | 230.36 |
Long-Term Leases | 1.11 | 0.79 | - | 0.16 | 0.41 | 0.26 |
Long-Term Unearned Revenue | 8.39 | 7.05 | 0.13 | 0.18 | 0.72 | 2.77 |
Long-Term Deferred Tax Liabilities | 38.83 | 40.36 | 43.35 | 46.72 | 50.93 | 55.87 |
Other Long-Term Liabilities | - | - | - | - | 128.86 | 318.11 |
Total Liabilities | 1,810 | 1,793 | 2,054 | 2,400 | 2,563 | 3,198 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Common Stock | 1,182 | 1,182 | 1,182 | 1,182 | 1,182 | 1,182 |
Additional Paid-In Capital | 528.04 | 528.04 | 528.04 | 528.04 | 528.04 | 528.04 |
Retained Earnings | -843.83 | -872.37 | -409.47 | 983.83 | 820.59 | 661.09 |
Total Common Equity | 866.43 | 837.89 | 1,301 | 2,694 | 2,531 | 2,371 |
Minority Interest | 73.04 | 71.17 | 73.14 | 71.86 | 68.88 | 72.09 |
Shareholders' Equity | 939.47 | 909.06 | 1,374 | 2,766 | 2,600 | 2,443 |
Total Liabilities & Equity | 2,750 | 2,702 | 3,428 | 5,166 | 5,163 | 5,642 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Total Debt | 1,280 | 931.36 | 1,278 | 1,564 | 1,672 | 1,840 |
Net Cash (Debt) | -1,068 | -792.39 | -1,114 | -1,332 | -1,450 | -1,423 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -0.90 | -0.67 | -0.94 | -1.13 | -1.23 | -1.20 |
Filing Date Shares Outstanding | 1,187 | 1,182 | 1,182 | 1,182 | 1,182 | 1,182 |
Total Common Shares Outstanding | 1,187 | 1,182 | 1,182 | 1,182 | 1,182 | 1,182 |
Working Capital | -271.52 | -480.66 | -361.65 | 1,275 | 700.13 | 517.09 |
Book Value Per Share | 0.73 | 0.71 | 1.10 | 2.28 | 2.14 | 2.01 |
Tangible Book Value | 385.45 | 345.94 | 266.47 | 1,556 | 1,373 | 1,179 |
Tangible Book Value Per Share | 0.32 | 0.29 | 0.23 | 1.32 | 1.16 | 1.00 |
Buildings | - | 1,110 | 1,098 | 1,096 | 1,089 | 1,082 |
Machinery | - | 1,421 | 1,378 | 1,347 | 1,385 | 1,401 |
Construction In Progress | - | 100.03 | 61.9 | 41.95 | 23.36 | 7.7 |